4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-017604
Director sold 10,000 shares at $3.45 ($34,500)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dorval Allison Director | 2023-06-13 | Sale 10b5-1 | −10,000 | $3.45 | $34,500 | 17,000 | D |
| Dorval Allison Director | 2023-06-13 | Grant or award 10b5-1 | +27,000 | 44,000 | D | ||
| Open-market sales · 10,000 sh · avg $3.45 · $34,500 | |||||||
Loading xslF345X04/rdgdoc.xml…